124 related articles for article (PubMed ID: 7443442)
1. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
Beaumont V
Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
[No Abstract] [Full Text] [Related]
2. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
[TBL] [Abstract][Full Text] [Related]
3. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W
Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746
[No Abstract] [Full Text] [Related]
4. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
[No Abstract] [Full Text] [Related]
5. [Effect of probucol on lipid and lipoprotein levels and serum apolipoproteins A1 and B in patients with hyperlipoproteinemia type II].
Sznajderman M; Zawadzki Z
Kardiol Pol; 1985; 28(10):628-36. PubMed ID: 3938501
[No Abstract] [Full Text] [Related]
6. [The effect of probucol of bile composition].
Marecek Z; Jirsa M; Kordac V; Kucerová K
Vnitr Lek; 1981 Jul; 27(7):667-70. PubMed ID: 7303501
[No Abstract] [Full Text] [Related]
7. [Effect of probucol on blood lipid level and lecithin acyltransferase activity in type II hyperlipoproteinemia].
Sznajderman M; Kuczyńska K
Pol Arch Med Wewn; 1981 Mar; 65(3):219-25. PubMed ID: 7255223
[No Abstract] [Full Text] [Related]
8. [Comparative effects of probucol and placebo on blood cholesterol in patients on long-term treatment (author's transl)].
Mc Caughan D
Nouv Presse Med; 1980 Oct; 9(40):3018-20. PubMed ID: 7443444
[TBL] [Abstract][Full Text] [Related]
9. [Comparative effect of probucol and clofibrate in patients with primary hypercholesterolemia].
Pasquali R; Melchionda N; Parenti M; Cavazzini MG; Biso P; Baraldi G; Sorrenti G; De Benedittis G; Labò G
Clin Ter; 1982 Dec; 103(5):509-20. PubMed ID: 7160143
[No Abstract] [Full Text] [Related]
10. Probucol and high-density-lipoprotein cholesterol.
Gagné C; Lupien PJ; Brun D; Moorjani S; Toussaint M
Can Med Assoc J; 1980 Sep; 123(5):356. PubMed ID: 7260778
[No Abstract] [Full Text] [Related]
11. Probucol and familial hypercholesterolemia.
Dauignon J; Bouthillier D
Can Med Assoc J; 1982 May; 126(9):1024-5. PubMed ID: 7074497
[No Abstract] [Full Text] [Related]
12. Treatment of homozygous familial hypercholesterolaemia with probucol.
Baker SG; Joffe BI; Mendelsohn D; Seftel HC
S Afr Med J; 1982 Jul; 62(1):7-11. PubMed ID: 7089781
[TBL] [Abstract][Full Text] [Related]
13. [Effects of probucol on skin cholesterol concentrations in patients with type II hyperlipoproteineamia (author's transl)].
Beaumont JL; Jacotot B; Buxtorf JC; Meliço-Silvestre AA; Beaumont V
Nouv Presse Med; 1980 Oct; 9(40):2995-3000. PubMed ID: 7443438
[TBL] [Abstract][Full Text] [Related]
14. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.
Mellies MJ; Gartside PS; Glatfelter L; Vink P; Guy G; Schonfeld G; Glueck CJ
Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291
[No Abstract] [Full Text] [Related]
15. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Atherosclerosis; 1980 Nov; 37(3):469-74. PubMed ID: 7458992
[TBL] [Abstract][Full Text] [Related]
16. Effect of probucol on bile composition in man.
Jirsa M; Marecek Z; Kerdac V; Kucerova L
Artery; 1982; 10(1):44-7. PubMed ID: 7092575
[No Abstract] [Full Text] [Related]
17. [Evaluation of the effect of probucol on blood lipids].
Giannini SD; Forti N; Ziliotto EE
Arq Bras Cardiol; 1981 Feb; 36(2):139-42. PubMed ID: 7325835
[No Abstract] [Full Text] [Related]
18. One year experience with probucol, a new hypocholesterolaemic agent.
Ng AS; Johan A; Quek SS; Tan IK
Singapore Med J; 1982 Aug; 23(4):191-3. PubMed ID: 7178901
[No Abstract] [Full Text] [Related]
19. [Hypolipidemic effects of DH581 during prolonged administration (author's transl)].
Nash DT
G Ital Cardiol; 1976; 6(3):550-5. PubMed ID: 1010207
[TBL] [Abstract][Full Text] [Related]
20. Probucol in patients resistant to the lipid-lowering effects of cholestyramine.
Mann JI; Jelfs R; Cassels E; Barker K; Simpson HC; Carter RC
Lancet; 1981 Feb; 1(8217):450. PubMed ID: 6110087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
